Diagnostic Products Corporation IMMULITE 1000 Analyzer (148)
Specialty: Endocrinology
Welcome to the PulseAid listing for the Diagnostic Products Corporation IMMULITE 1000 Analyzer medical device. This device is used in the Endocrinology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Endocrinology healthcare specialty at the bottom of the page.
Analytes Measured/Detected and Complexity:
| ANALYTE | COMPLEXITY |
| Adrenocorticotropic hormone (ACTH) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Albumin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Allergen specific IgE and/or mixed allergen panel IgE (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Alpha-fetoprotein – tumor marker (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Amphetamines (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Androstenedione (X060027 | X060027) | MODERATE Effective Date: 2006-12-15 |
| Anti-thyroglobulin antibodies (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Anti-thyroid peroxidase (TPO) antibodies (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Beta-2 microglobulin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| C-peptide (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| C-reactive protein (CRP) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Calcitonin (K023304 | K023304) | MODERATE Effective Date: 2002-12-04 |
| Cancer antigen 125 (CA 125) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Cancer antigen 15-3 (CA 15-3) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Cannabinoids (THC) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Carbamazepine (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Carcinoembryonic antigen (CEA) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Cocaine metabolites (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Collagen type I crosslink, deoxypyridinoline (DPD) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Cortisol (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Creatine kinase MB fraction (CKMB) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Cytomegalovirus antibodies (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Dehydroepiandrosterone sulfate (DHEA-SO4) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Digitoxin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Digoxin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Erythropoietin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Estradiol (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Estriol, unconjugated (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Ferritin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Folate (folic acid) (K022603 | K022603) | HIGH Effective Date: 2002-10-30 |
| Follicle stimulating hormone (FSH) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Gastrin (X060027 | X060027) | MODERATE Effective Date: 2006-12-15 |
| hCG, total, serum, quantitative (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Helicobacter pylori antibodies (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Hepatitis B core antibody (P010051 | P010051/S001) | MODERATE Effective Date: 2003-08-25 |
| Hepatitis B core antigen (P010053 | P010053/S001) | MODERATE Effective Date: 2003-08-25 |
| Herpes simplex I and/or II antibodies (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Homocysteine (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Human growth hormone (GH) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Human placental lactogen (HPL) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Immunoglobulins IgE (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Insulin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Insulin-like growth factor binding protein3 (IGFBP-3) (X060027 | X060027) | MODERATE Effective Date: 2006-12-15 |
| Insulin-like growth factor-1 (IGF-1) (X060027 | X060027) | MODERATE Effective Date: 2006-12-15 |
| Luteinizing hormone (LH) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Methamphetamines (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Myoglobin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Parathyroid hormone – intact (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Phenobarbital (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Phenytoin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Progesterone (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Prolactin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Prostatic acid phosphatase (PAP) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Rubella antibodies (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Sex hormone binding globulin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Testosterone (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Theophylline (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Thyroglobulin (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Thyroid stimulating hormone (TSH) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Thyroxine (T4) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Thyroxine binding globulin (TBG) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Thyroxine uptake (T4U) (TU) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Thyroxine, free (FT4) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Toxoplasma gondii antibodies (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Triiodothyronine (T3) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Triiodothyronine, free (FT3) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Troponin-I (cardiac) (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Valproic acid (K022603 | K022603) | MODERATE Effective Date: 2002-10-30 |
| Vitamin B12 (K022603 | K022603) | HIGH Effective Date: 2002-10-30 |
Other Diagnostic Products Corporation IMMULITE 1000 Analyzer Medical Devices:
| Medical Device | Complexity |
| Diagnostic Products Corporation IMMULITE 1000 Analyzer (3921) Testosterone | | View Complexity |